日本ケミファ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2021/12/03 | 日証協 | 13,271株 | +12.74% | 3,461株 | +3361% | 38,184株 | +4.38% | 7,513株 | +47.75% |
| 2021/11/26 | 日証協 | 11,771株 | -8.55% | 100株 | -95.79% | 36,580株 | +3.86% | 5,085株 | +111.88% |
| 2021/11/19 | 日証協 | 12,871株 | +5.75% | 2,374株 | +122.28% | 35,220株 | +1.15% | 2,400株 | +300% |
| 2021/11/05 | 日証協 | 12,071株 | +2.44% | 1,274株 | -52.81% | 35,317株 | +3.93% | 3,344株 | +3.21% |
| 2021/10/29 | 日証協 | 11,784株 | +29.72% | 2,700株 | +440% | 33,982株 | +4.31% | 3,240株 | +30.12% |
| 2021/10/22 | 日証協 | 9,084株 | -24.36% | 500株 | +150% | 32,579株 | -6.87% | 2,490株 | -22.41% |
| 2021/10/15 | 日証協 | 12,009株 | -9.08% | 200株 | -92.59% | 34,982株 | -2.51% | 3,209株 | -49.85% |
| 2021/10/08 | 日証協 | 13,209株 | +14.06% | 2,700株 | +79.52% | 35,882株 | -10.86% | 6,399株 | -65.73% |
| 2021/10/01 | 日証協 | 11,581株 | -4.89% | 1,504株 | +150.67% | 40,254株 | -4.95% | 18,672株 | +1567.14% |
| 2021/09/24 | 日証協 | 12,177株 | +0.83% | 600株 | -66.67% | 42,350株 | -0.52% | 1,120株 | -73.4% |
| 2021/09/17 | 日証協 | 12,077株 | +4.32% | 1,800株 | -54.19% | 42,570株 | +4.31% | 4,210株 | -24.94% |
| 2021/09/10 | 日証協 | 11,577株 | +19.8% | 3,929株 | +231% | 40,813株 | +1.43% | 5,609株 | +33.42% |
| 2021/09/03 | 日証協 | 9,664株 | -0.9% | 1,187株 | -45.25% | 40,238株 | +1.83% | 4,204株 | -11.68% |
| 2021/08/27 | 日証協 | 9,752株 | +14.95% | 2,168株 | +688.36% | 39,513株 | +0.43% | 4,760株 | -18% |
| 2021/08/20 | 日証協 | 8,484株 | -0.8% | 275株 | +2.61% | 39,345株 | +6.52% | 5,805株 | -34.08% |
| 2021/08/13 | 日証協 | 8,552株 | -1.52% | 268株 | +34% | 36,935株 | -1.86% | 8,806株 | -3.45% |
| 2021/08/06 | 日証協 | 8,684株 | -6.46% | 200株 | -83.33% | 37,635株 | -0.19% | 9,121株 | -25.44% |
| 2021/07/30 | 日証協 | 9,284株 | -5.11% | 1,200株 | +500% | 37,705株 | +0.67% | 12,233株 | +19.6% |
| 2021/07/21 | 日証協 | 9,784株 | -6.68% | 200株 | -88.73% | 37,453株 | -5.27% | 10,228株 | -24.96% |
※株式分割は考慮していませんのでご注意ください。